Gabon
Tuberculosis profile
| High HIV burden |
Population  2012 1.6 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.72 (0.3–1.3) 44 (18–81)
Mortality (HIV+TB only) 0.51 (0.45–0.62) 32 (28–38)
Prevalence  (includes HIV+TB) 9.2 (4.3–16) 563 (265–971)
Incidence  (includes HIV+TB) 7 (5.8–8.3) 428 (354–510)
Incidence (HIV+TB only) 1.9 (1.5–2.2) 115 (95–137)
Case detection, all forms (%) 71 (59–85)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 1 745 (39) Relapse 175 (26)
Smear-negative 1 236 (27) Treatment after failure 68 (10)
Smear-unknown / not done 1 117 (25) Treatment after default 188 (28)
Extrapulmonary 414 (9) Other 230 (35)
Other 0 (0)      
Total new 4 512   Total retreatment 661  
           
Other (history unknown) 242        
Total new and relapse 4 687   Total cases notified 5 415  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.7 1.2 1.4
Age < 15 71 233 37
Laboratories 2012
Smear (per 100 000 population) 0.9
Culture (per 5 million population) 3.1
Drug susceptibility testing (per 5 million population) 3.1
Is second-line drug susceptibility testing available? No
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 51   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 46  
Retreatment 40  
TB/HIV 2012 Number (%)
TB patients with known HIV status 5 415 (100)
HIV-positive TB patients 852 (16)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART) 559 (66)
HIV-positive people screened for TB 286  
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 2.5 (0.01–5) 10 (3.5–17)
MDR-TB cases among notified pulmonary
TB cases
100 (0–200) 67 (23–110)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB      
Laboratory-confirmed MDR-TB cases     0
Patients started on MDR-TB treatment     0
Financing TB control 2013
National TB programme budget (US$ millions) 73
% Funded domestically 2%
% Funded internationally <1%
% Unfunded 98%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-16 Data: www.who.int/tb/data